novavax

AMA Update 501: CDC COVID-19 vaccine guidelines: When is the new COVID vaccine coming out in 2024?

What is the newest COVID vaccine called? When is the new COVID vaccine available? Which COVID 19 vaccine is best? What are the CDC COVID guidelines for vaccines? Our guest is Sandra Fryhofer, MD, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and a member of ACIP’s COVID-19 Vaccine Workgroup. American Medical Association CXO Todd Unger hosts.

🩺 The AMA is your powerful ally, focused on addressing the issues important to you, so you can focus on what matters most — patients. We will meet this challenge together. Join us: https://ama-assn.co/JoinRenew

🦠 Looking for a COVID map? Get the latest CDC COVID Tracker map, charts and data: https://ama-assn.co/CDC_COVID

💉 Searching for «COVID vaccine near me»? Find vaccines in your area at: https://ama-assn.co/COVID_vaccine

Read More

AMA Update 371: Latest FDA Novavax approval, new long COVID study data, plus CDC updates STI treatment guidelines

The updated COVID-19 vaccine from Novavax will be available this week. AMA’s Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, discusses the latest vaccine authorization, the discontinuation of the COVID-19 vaccination card and a new study that found differences in the blood of people with Long COVID. Plus, CDC draft recommendations on Doxy-PEP for STI prevention. American Medical Association CXO Todd Unger hosts.

🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew

Read More

AMA Update 211: Novavax booster, COVID vaccines in pregnancy and boosters for kids with Sandra Fryhofer, MD

Sandra Fryhofer, MD, the AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP) and chair of the AMA Board of Trustees, shares news from the latest ACIP meeting, including the newest COVID booster from Novavax, more reassuring data on the safety and value of COVID vaccines for pregnant people, their infants and children, and the inclusion of COVID vaccines in the Vaccines for Children Program. American Medical Association CXO Todd Unger hosts.

Read More

AMA Update 176: FDA authorizes Novavax vaccine for kids ages 12-17 with Andrea Garcia, JD, MPH

AMA’s Director of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, shares news on the Novavax vaccine from the FDA—as well as updates on COVID boosters for fall, monkeypox vaccines, TPOXX treatments, and Dr. Anthony Fauci’s announcement on stepping down from the National Institute of Allergy and Infectious Diseases (NIAID). American Medical Association CXO Todd Unger hosts.

Read More

AMA Update 166: Novavax vaccine questions answered with Sandra Fryhofer, MD

Novavax vaccine dose, delivery, storage, side effects—and all the details doctors need to know with Sandra Fryhofer, MD, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and a member of ACIP’s COVID-19 Vaccine Workgroup. American Medical Association CXO Todd Unger hosts.

AMA COVID-19 resource center for physicians: http://ama-assn.org/covid-19

Read More

AMA Update 165: Monkeypox, Omicron BA.5, and Novavax with Andrea Garcia, JD, MPH

AMA Director of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, details summer spike of COVID-19 cases driven by the highly transmissible Omicron BA.5 subvariant. Also covering Novavax news, as well as monkeypox cases and stats—including the World Health Organization (WHO) declaring it a global health emergency. American Medical Association CXO Todd Unger hosts.

Read More

AMA Update 146: FDA to review COVID vaccine for kids under 5 with Andrea Garcia, JD, MPH

AMA CXO Todd Unger reviews the latest timeline on Moderna and Pfizer vaccine authorizations for young children with AMA Director of Science, Medicine and Public Health, Andrea Garcia. Also covering the rise in COVID cases, FDA’s proposed timing to review data on Novavax and variant-specific vaccines, as well as how to spot fake COVID-19 at-home tests.

Read More

AMA Update 119: Andrea Garcia, JD, MPH, covers new CDC study findings, full FDA approval for Moderna vaccine & Novavax authorization request

AMA CXO Todd Unger reviews COVID-19 case numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Including the new “stealth Omicron” variant, as well as data from the latest CDC study showing third doses/booster shots bolster COVID defenses for both the immunocompromised and people with stronger immune systems. Also recapping AMA’s joint statement with the American Hospital Association (AHA) and the American Nurses Association (ANA) on blood shortages.

Read More

AMA Update 50: Dr. Mira Irons shares insights on continuing vaccination efforts and Novavax details

Discussion with AMA’s Chief Health and Science Officer, Dr. Mira Irons, to review COVID-19 vaccine numbers and trending topics related to the pandemic over the past week. Also covering 600,000 deaths, Novavax details, the Delta variant and the June 2021 Special Meeting of the AMA House of Delegates.

Read More